Maximize NIH and DOD Funding

The FreeMind Group is the premier international consulting firm specializing in assisting life science organizations secure non-dilutive funding from US Federal Agencies and Private Foundations


The FreeMind Group turns non-dilutive funding into a strategic source of funding for life science organizations

Meet us at an upcoming event:

All Upcoming Events →



Established in 1999, FreeMind is the largest consulting group of its kind with over 400 active clients, academics and Industry alike. Our goal is to assist in maximizing potential to receive funding from non-dilutive sources. We have experience in seeking funding from nearly all NIH Institutes, Department of Defense, NSF, FDA, BARDA, etc., as well as private foundations.


FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our expertise in applying for grants and contracts extends throughout every government mechanism as well as private foundations open to funding the life sciences.


FreeMind’s proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Awards range from $150,000 to $100,000,000 per project. Our team of experts will assist in making non-dilutive funding a key tool in a long-term sound financial strategy.


Ram May-Ron
Ram May-Ron
Managing Partner
Ayal Ronen, M.Sc., MBA
Ayal Ronen, M.Sc., MBA
Vice President
Guy Har-Chen, M.Sc., MBA
Guy Har-Chen, M.Sc., MBA
Chief Analyst
Joel Knopf, M.Sc., MBA
Joel Knopf, M.Sc., MBA
Manager of Consulting Services
Sigal Katz, Ph.D.
Sigal Katz, Ph.D.
Senior Analyst
Inna Grodzovski, Ph.D.
Inna Grodzovski, Ph.D.
Senior Analyst
Merav Geva, Ph.D.
Merav Geva, Ph.D.
Senior Analyst
Ariel Shatz
Ariel Shatz
Executive Vice President

Strategic Partners

  • onemedplace
  • ebd-group
  • ibf
  • sachs_lge
  • elsevier
  • advamed
  • wbr
  • OBN
  • LSN_logo
  • IIR
  • Biotech and Money

Services at a Glance

Core Services:

  1. STRATEGIC ASSESSMENT  – Identification and strategy as to applicable funding sources
  2. GRANT PRODUCTION PROCESS – Maximizing chances for a award utilizing a proven strategic approach


FreeMind’s professional staff has assisted in attaining funding for R&D activities from all available sources and mechanisms stemming primarily from the National Institutes of Health (NIH) as well as Department of Defense (DoD).


We have helped organizations across the life sciences secure funding from these zero-equity sources. We have worked with many academic institutions, as well as industry members from small start-ups through large pharmaceutical companies.




Large Scale Funding

Multidisciplinary grants and contracts available for pre-clinical as well as clinical stage research with budgets of $10 million – $150 million per project


Small Business Research and Development grants can be budgeted $150,000 for SBIR/STTR Phase I awards and up to $2 million  for SBIR/STTR Phase II awards.

Targeted Solicitations

UO1s, BAAs, RFPs implemented science and developmental awards with budgets of $3 million – $7 million per project

R21s, and R01s

Basic research, preclinical, and unsolicited grants focusing on early as well as late-stage preclinical research and can be budgeted $1 million – $3 million per project


The Process


Strategic Assessment

This step is designed to provide a robust, long-term, multi-submission strategy for each pipeline project. FreeMind is well versed in the interests, goals and agendas of each NIH Institute. We review the suitability of a proposed project, taking into consideration the significance to public health, innovative factor, strength of research approach, and specific concerns regarding the nature of the project


Macro Application Strategy

First, we outline the specific aims and scope of work. Next, the size of the budget is set, and collaborators, subcontractors, and consultants needed for a complete and rounded project are delineated. We devise a timeline and an orderly division of responsibilities in order to facilitate a timely and thorough completion of tasks

Grant production process

Project managers draft comprehensive templates. From this point, the writing effort is combined and is largely based on on-going feedback, comments and edits inserted by the project managers and in response to portions implemented by the client. The iterative review concludes when a well structured scientifically sound application with all items accounted for materializes.

Submission and follow up

After extensive editing and formatting, the application is ready for submission. Post-submission, project managers track the application and when applicable assists in the award negotiation phase. FreeMind closely follows all deadlines for supplementary data, study section reviews, and final decision by the granting agency

FreeMind’s knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award



Non Dilutive Funding – Non di-lu’-tive Fund-ing

1. funding – financial resources provided to make some project possible; “the National Institute of Health (NIH) provided support for the experiment”

2. non-dilutive funding – the act of financing R&D activity not traded for public securities and/or shares of a commercial entity; “The FreeMind Group assisted in securing non-dilutive funding from the Department of Defense for a Phase II clinical trial”

FreeMind Summer School

Weekly Online Educational Webinars - July 1st - August 19th, 2015

Participation is FREE of Charge, Registration is Required



July 1, 2015

Watch Recording

SBIR/STTR Funding; Driving Innovation through Non-Dilutive Sources

more information

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we will discuss process for applying, guidelines, key success components and insight into increasing chances for award.

July 8, 2015

Watch Recording

Funding beyond the SBIR/STTR; RO1s and R21s for Companies

more information

Every year NIH alone awards over $120,000,000 via R’-Mechanisms, among them the RO1 or R21. In order to maximize your funding potential all sources of funding must be considered including the less traditional sources.

R21s aim to fund very early stage proof of concept type programs of up to 2 years at about $300,000, whereas RO1s are more suitable for longer programs of up to 5 years, totaling some $3,000,000.

In this webinar FreeMind experts will share insight into alternatives to the classic SBIR/STTR mechanisms. We will discuss methodology for establishing both responsiveness as well as competitiveness and how to increase chances for award.

July 15, 2015

Watch Recording

Biodefense and Infectious Diseases Non-dilutive Funding

more information

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA etc. this is a funding force no one in the field can afford to ignore.

Listen to FreeMind experts share insights into these tremendous sources of funding and get tips on how to maximize potential to receive an award.

July 22, 2015

Watch Recording

Non-Dilutive funding for Non-US applicants

more information

Non-US applicants are eligible for the majority of the non-dilutive pockets of money including NIH, Department of Defense, BARDA etc. Currently, the National Institutes of Health (NIH) are actively funding over 1000 projects in the excess of $1.3B, taking place outside the US and awarded to non-US applicant organizations. And, when taking into account collaborations and partnerships between domestic and foreign entities, the funded R&D dollars outside the US even exceed the above.

In this presentation we will provide insight into the non-dilutive funding landscape with an emphasis on the NIH, Department of Defense and other government agencies. FreeMind experts will describe the various pockets of money available for non-US applicants, potential for funding, and means to maximize chances for award.

July 29, 2015

Watch Recording

U-Mechanism; Cooperative Agreements

more information

The U-Mechanism is a support mechanism used when there will be substantial Federal scientific or programmatic involvement by granting agency. Substantial involvement means that, after award, scientific or program staff will assist, guide, coordinate, or participate in project activities.

We are seeing many programs utilizing this type of mechanism, with substantial awards being made to industry as well.

In this webinar we will discuss process for applying, guidelines, key success components, and insight into increasing chances for award when pursuing U-based opportunities

August 5, 2015

Watch Recording

Medical Device Non-Dilutive Funding: Trends & Opportunities

more information

In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies.

The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation.

In the webinar in the series of summer educational webinars FreeMind experts will discuss the latest trends at the NIH and the new available funding opportunities with respect to medical devices.

August 12, 2015

Watch Recording

CNS/PNS Related Non-Dilutive Funding Opportunities

more information

Within the non-dilutive funding space one can find pockets of money in the billions of dollars directed at unmet medical needs related to CNS/PNS ailments. The scope of funding support covers much of the R&D cycle from proof of concept to late stage clinical.

In the webinar in the series of summer educational webinars FreeMind experts will discuss key CNS/PNS related funding opportunities, with an emphasis on NINDS, NIA, and NIMH.

August 19, 2015

Watch Recording

Cancer Non-dilutive Funding

more information

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well.

In the upcoming webinar in the series of summer educational webinars FreeMind experts will discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for Life Science organizations.

The webinars are designed for first timers as well as seasoned grantees. FreeMind experts will share their insight into various areas of interest as they relate to non-dilutive sources of funding and how to maximize chances for award.

For any inquiries, please email Carla Hamoy: Send Mail


All Webinars are recorded and posted on the FreeMind Group Educational YouTube Channel


FreeMind’s knowledgeable team of expert grant writers share their wisdom on how to maximize chances for award.

Join our mailing list by typing in your email address here:

* Don’t worry, we hate spam as much as you do.


Get in touch with us

For any inquiry or question please contact us by phone or email.

US Office

FreeMind Group
423 Brookline Ave. #124
Boston, MA 02215

Tel: (617) 648-0340
Fax: (617) 904-1767

International Office

FreeMind Group
Hi – Tech Center
Hebrew University
Jerusalem 95702 Israel

Tel: +972 (0)2-6799833
Fax: +972 (0)2-6799834

Contact us using this form

Blog Categories

Join our Mailing List

* Don't worry, we hate spam as much as you do.
Contact us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Questions, issues or concerns? I'd love to help you!

Click ENTER to chat